Mitochondria-targeted antioxidant AntiOxBEN2 prevents metabolic dysfunction-associated steatotic liver disease (MASLD) by enhancing fatty acid oxidation and mitochondrial bioenergetics
Ricardo José Rocha Amorim, Carina C. Magalhães, Ana I. Duarte, Alexandra C de Lemos et autres